| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |